About this Journal Submit a Manuscript Table of Contents
Obstetrics and Gynecology International
Volume 2012 (2012), Article ID 306347, 11 pages
http://dx.doi.org/10.1155/2012/306347
Clinical Study

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Clinic of Endocrinology, University Hospital Alexandrovska, Medical University-Sofia, 1 Georgi Sofiiski Boulevard, 1431 Sofia, Bulgaria

Received 31 July 2011; Accepted 10 November 2011

Academic Editor: W. T. Creasman

Copyright © 2012 Antoaneta Gateva and Zdravko Kamenov. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Asunción, R. M. Calvo, J. L. San Millá, J. Sancho, S. Avila, and H. F. Escobar-Morreale, “A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 7, pp. 2434–2438, 2000. View at Publisher · View at Google Scholar
  2. E. S. Knochenhauer, T. J. Key, M. Kahsar-Miller, W. Waggoner, L. R. Boots, and R. Azziz, “Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 9, pp. 3078–3082, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif, “Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 165–169, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Nestler, “Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications,” Seminars in Reproductive Endocrinology, vol. 15, no. 2, pp. 111–122, 1997.
  5. J. E. Nestler and D. J. Jakubowicz, “Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4075–4079, 1997.
  6. J. E. Nestler and D. J. Jakubowicz, “Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome,” New England Journal of Medicine, vol. 335, no. 9, pp. 617–623, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. D. A. Ehrmann, R. B. Barnes, R. L. Rosenfield, M. K. Cavaghan, and J. Imperial, “Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome,” Diabetes Care, vol. 22, no. 1, pp. 141–146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif, “Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 165–169, 1999. View at Publisher · View at Google Scholar
  9. P. Björntorp, “The android woman—a risky condition,” Journal of Internal Medicine, vol. 239, no. 2, pp. 105–110, 1996. View at Scopus
  10. J. Vrbáková, R. Cífková, A. Jirkovská et al., “Cardiovascular risk factors in young Czech females with polycystic ovary syndrome,” Human Reproduction, vol. 18, no. 5, pp. 980–984, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Talbott, D. Guzick, A. Clerici et al., “Coronary heart disease risk factors in women with polycystic ovary syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 7, pp. 821–826, 1995. View at Scopus
  12. E. Talbott, A. Clerici, S. L. Berga et al., “Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study,” Journal of Clinical Epidemiology, vol. 51, no. 5, pp. 415–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Wild, P. Alaupovic, and I. J. Parker, “Lipid and apolipoprotein abnormalities in hirsute women: the association with insulin resistance,” American Journal of Obstetrics and Gynecology, vol. 166, no. 4, pp. 1191–1197, 1992. View at Scopus
  14. R. A. Wild, “Obesity, lipids, cardiovascular risk, and androgen excess,” American Journal of Medicine, vol. 98, no. 1 A, pp. 27S–32S, 1995. View at Publisher · View at Google Scholar
  15. G. Paradisi, H. O. Steinberg, A. Hempfling et al., “Polycystic ovary syndrome is associated with endothelial dysfunction,” Circulation, vol. 103, no. 10, pp. 1410–1415, 2001. View at Scopus
  16. K. Lakhani, N. Constantinovici, W. M. Purcell, R. Fernando, and P. Hardiman, “Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries,” Lancet, vol. 356, no. 9236, pp. 1166–1167, 2000. View at Scopus
  17. C. J. Kelly, A. Speirs, G. W. Gould, J. R. Petrie, H. Lyall, and J. M. C. Connell, “Altered vascular function in young women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 742–746, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Azziz, K. S. Woods, R. Reyna, T. J. Key, E. S. Knochenhauer, and B. O. Yildiz, “The prevalence and features of the polycystic ovary syndrome in an unselected population,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2745–2749, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. H. Balen, G. S. Conway, G. Kaltsas et al., “Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients,” Human Reproduction, vol. 10, no. 8, pp. 2107–2111, 1995. View at Scopus
  20. C. J. Glueck, S. Dharashivkar, P. Wang et al., “Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 122, no. 2, pp. 206–212, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. T. Apridonidze, P. A. Essah, M. J. Iuorno, and J. E. Nestler, “Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 1929–1935, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T. Douchi, H. Ijuin, S. Nakamura, T. Oki, S. Yamamoto, and Y. Nagata, “Body fat distribution in women with polycystic ovary syndrome,” Obstetrics and Gynecology, vol. 86, no. 4, pp. 516–519, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Acien, F. Quereda, and P. Matallin, “Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders,” Fertility and Sterility, vol. 72, no. 1, pp. 32–40, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. D. R. Haun, F. J. Pitanga, and I. Lessa, “Waist-height ratio compared with other anthropometric indicators of obesity as a predictor of high coronary risk,” Revista da Associacao Medica Brasileira, vol. 55, no. 6, pp. 705–711, 2009. View at Scopus
  25. H. J. Schneider, H. Glaesmer, J. Klotsche et al., “Accuracy of anthropometric indicators of obesity to predict cardiovascular risk,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 589–594, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Gambineri, C. Pelusi, V. Vicennati, U. Pagotto, and R. Pasquali, “Obesity and the polycystic ovary syndrome,” International Journal of Obesity and Related Metabolic Disorders, vol. 26, no. 7, pp. 883–896, 2002. View at Publisher · View at Google Scholar · View at PubMed
  27. R. J. Norman, M. J. Davies, J. Lord, and L. J. Moran, “The role of lifestyle modification in polycystic ovary syndrome,” Trends in Endocrinology and Metabolism, vol. 13, no. 6, pp. 251–257, 2002. View at Publisher · View at Google Scholar
  28. B. O. Yildiz, E. S. Knochenhauer, and R. Azziz, “Impact of obesity on the risk for polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 1, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. P. Vigil, P. Contreras, J. Alvarado, A. Godoy, A. Salgado, and M. Cortés, “Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome,” Human Reproduction, vol. 22, no. 11, pp. 2974–2980, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. I. Zavaroni, P. Coruzzi, L. Bonini et al., “Association between salt sensitivity and insulin concentrations in patients with hypertension,” American Journal of Hypertension, vol. 8, no. 8, pp. 855–858, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. L. M. Resnick, “Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders,” American Journal of Medicine, vol. 93, no. 2 A, pp. 11S–20S, 1992.
  32. R. Pasquali and A. Gambineri, “Mechanisms and treatment of obesity in PCOS,” in From the Ovary to the Pancreas: Current Concepts and Controversies in the Polycystic Ovary Syndrome Totowa, A. Dunaif, R. J. Chang, S. Franks, et al., Eds., Humana Press, Totowa, NJ, USA, 2006.
  33. “Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002.
  34. K. J. Mather, F. Kwan, and B. Corenblum, “Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity,” Fertility and Sterility, vol. 73, no. 1, pp. 150–156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Danesh, R. Collins, P. Appleby, and R. Peto, “Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies,” Journal of the American Medical Association, vol. 279, no. 18, pp. 1477–1482, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. K. L. Margolis, J. E. Manson, P. Greenland et al., “Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study,” Archives of Internal Medicine, vol. 165, no. 5, pp. 500–508, 2005. View at Publisher · View at Google Scholar · View at PubMed
  37. B. D. Horne, J. L. Anderson, J. M. John, Intermountain Heart Collabarative Study Group, et al., “Which white blood cell subtypes predict increased cardiovascular risk?” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1638–1643, 2005. View at Publisher · View at Google Scholar · View at PubMed
  38. F. Orio Jr., S. Palomba, T. Cascella et al., “The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 2–5, 2005. View at Publisher · View at Google Scholar · View at PubMed
  39. N. T. Shahidi, “Androgens and erythropoiesis,” New England Journal of Medicine, vol. 289, no. 2, pp. 72–80, 1973. View at Scopus
  40. V. Bhatia, A. Chaudhuri, R. Tomar, S. Dhindsa, H. Ghanim, and P. Dandona, “Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes,” Diabetes Care, vol. 29, no. 10, pp. 1–6, 2006.
  41. T. Sir-Petermann, B. Angel, M. Maliqueo, F. Carvajal, J. L. Santos, and F. Pérez-Bravo, “Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome,” Diabetologia, vol. 45, no. 7, pp. 959–996, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. B. O. Yildiz, H. Yarali, H. Oguz, and M. Bayraktar, “Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 5, pp. 2031–2036, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. Ehrmann, K. Kasza, R. Azziz, R. S. Legro, and M. N. Ghazzi, “Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 66–71, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. K. M. Knowles, L. L. Paiva, S. E. Sanchez, et al., “Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among peruvian adults,” International Journal of Hypertension, vol. 2011, Article ID 931402, 10 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  46. C. M. Y. Lee, R. R. Huxley, R. P. Wildman, and M. Woodward, “Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis,” Journal of Clinical Epidemiology, vol. 61, no. 7, pp. 646–653, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. Orbetsova, V. Orbetsova, Z. Kamenov, et al., “Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS),” Akush Ginekol, vol. 42, no. 4, pp. 10-5–15, 2003.